Pazopanib (P) and cisplatin (CDDP) in patients with advanced solid tumors: A UNICANCER phase I study.
Veronique Dieras
Honoraria - GlaxoSmithKline
Thomas Bachelot
No relevant relationships to disclose
Mario Campone
Consultant or Advisory Role - Novartis; SERVIER
Honoraria - Novartis; SERVIER
Nicolas Isambert
No relevant relationships to disclose
Florence Joly
Honoraria - GlaxoSmithKline
Christophe Le Tourneau
No relevant relationships to disclose
Philippe Alexandre Cassier
Consultant or Advisory Role - SERVIER
Honoraria - GlaxoSmithKline; Novartis
Research Funding - Novartis; Roche
Other Remuneration - Novartis; SERVIER
Emmanuelle Bompas
No relevant relationships to disclose
Pierre Fumoleau
No relevant relationships to disclose
Sabine Noal
No relevant relationships to disclose
Christine Orsini
No relevant relationships to disclose
Marta Jimenez
No relevant relationships to disclose
Diane Charlotte Imbs
No relevant relationships to disclose
Etienne Chatelut
No relevant relationships to disclose